Journal Article

The PROTEKT global study (year 4) demonstrates a continued lack of resistance development to telithromycin in <i>Streptococcus pneumoniae</i>

David J. Farrell and David Felmingham

in Journal of Antimicrobial Chemotherapy

Published on behalf of British Society for Antimicrobial Chemotherapy

Volume 56, issue 4, pages 795-797
Published in print October 2005 | ISSN: 0305-7453
Published online August 2005 | e-ISSN: 1460-2091 | DOI: https://dx.doi.org/10.1093/jac/dki282
The PROTEKT global study (year 4) demonstrates a continued lack of resistance development to telithromycin in Streptococcus pneumoniae

Show Summary Details

Journal Article.  789 words. 

Subjects: Medical Oncology ; Critical Care

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.